NCT05286931View on ClinicalTrials.gov

SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection

NARecruitingINTERVENTIONAL
Enrollment

1,800

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Neisseria Gonorrhoeae Infection
Interventions
DRUG

Ciprofloxacin 500 mg

Ciprofloxacin 500 MG, taken once orally.

Trial Locations (1)

98104

RECRUITING

Public Health -- Seattle & King County Sexual Health Clinic, Seattle

All Listed Sponsors
lead

University of Washington

OTHER